News
IPDQF
0.0045
NaN%
--
ImpediMed Director Increases Stake via Tranche 2 Placement
TipRanks · 06/16 22:58
ImpediMed director boosts stake via placement-linked share and option issue
TipRanks · 06/16 22:58
ImpediMed Director Deepens Stake via Tranche 2 Share Placement
TipRanks · 06/16 22:58
ImpediMed director vastly increases stake through approved share placement
TipRanks · 06/16 22:57
ImpediMed Reveals Top Holders for Newly Quoted ASX Options
TipRanks · 06/16 12:25
ImpediMed Confirms Compliance as It Issues 1.32 Billion New Shares
TipRanks · 06/16 12:25
Impedimed Seeks ASX Quotation for Massive New Share and Option Issuance
TipRanks · 06/16 12:24
ImpediMed raises A$2.1m in oversubscribed share purchase plan
TipRanks · 06/09 23:24
ImpediMed Director Receives Equity in Lieu of Board Fees
TipRanks · 06/03 02:39
ImpediMed Director Increases Shareholding Through Fee-in-Shares Arrangement
TipRanks · 06/03 02:38
ImpediMed director increases shareholding through fee-for-equity arrangement
TipRanks · 06/03 02:38
ImpediMed director boosts indirect stake via fee-paid share issue
TipRanks · 06/03 02:37
ImpediMed boosts director equity through fee-based share issuance
TipRanks · 06/03 02:37
Impedimed Seeks ASX Quotation for Director Fee Share Issuance
TipRanks · 06/03 02:28
ImpediMed Sets Closing Date for $2 Million Share Purchase Plan
TipRanks · 06/02 01:52
ImpediMed targets growth with new leadership, stronger SOZO traction across key segments
TipRanks · 06/02 01:52
ImpediMed Details Online Access for June Extraordinary General Meeting
TipRanks · 05/12 23:49
ImpediMed Calls Extraordinary General Meeting for June 2026
TipRanks · 05/12 23:47
Ord Minnett Keeps Their Buy Rating on Impedimed Limited (IPDQF)
TipRanks · 05/12 01:06
ImpediMed launches share purchase plan as part of A$15.2m capital raise
TipRanks · 05/11 22:53
More
Webull provides a variety of real-time IPDQF stock news. You can receive the latest news about Impedimed through multiple platforms. This information may help you make smarter investment decisions.
About IPDQF
ImpediMed Limited is an Australia-based medical technology company. The Company uses bioimpedance spectroscopy (BIS) technology to generate data to maximize patient health. The Company designs and manufactures medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company’s SOZO Digital Health Platform is a Food and Drug Administration (FDA)-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema. Its SOZO Applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp Analysis, and HF-Dex Analysis for Heart Failure. Its product SFB7 measures fluid status and tissue composition for clinical and research applications. Its ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications.